Cargando…
Outbreaks of iatrogenic botulism in Europe: Combating off-label medical use of Botulinum Neurotoxin (BoNT) in bariatric procedures
Autores principales: | Jain, Nityanand, Lansiaux, Edouard, Yucel, Umut, Huenermund, Swantje, Goeschl, Stella, Schlagenhauf, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333734/ https://www.ncbi.nlm.nih.gov/pubmed/37441153 http://dx.doi.org/10.1016/j.nmni.2023.101152 |
Ejemplares similares
-
Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
por: Valdezate, Sylvia, et al.
Publicado: (2023) -
Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
por: Smith, Theresa J., et al.
Publicado: (2023) -
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
por: Webb, Robert P., et al.
Publicado: (2017) -
Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)
por: Bai, Lili, et al.
Publicado: (2018) -
Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
por: Lou, Jianlong, et al.
Publicado: (2018)